University of Miami Miller School of Medicine

What University of Miami Miller School of Medicine does

The University of Miami Leonard M. Miller School of Medicine is the graduate medical school of the University of Miami, founded in 1952 as the oldest medical school in Florida. It operates as a private, nonprofit academic medical center from a 72-acre campus within the 153-acre University of Miami/Jackson Memorial Medical Center complex in Miami's Health District, with 1,001–5,000 employees. The institution integrates three core missions: medical education (M.D., M.D./Ph.D., dual-degree, graduate, postdoctoral, and ACCME-accredited continuing medical education programs); clinical care delivered through UHealth — University of Miami Health System, anchored by a 560-bed UHealth Tower and more than a dozen outpatient clinics across Miami-Dade, Broward, Palm Beach, and Collier counties; and biomedical research spanning 1,600+ projects backed by over $200 million in external grants.

The Miller School's clinical and research portfolio is organized around flagship institutes including Bascom Palmer Eye Institute (#1 ophthalmology hospital in the U.S. for 24 consecutive years), Sylvester Comprehensive Cancer Center (translational cancer care with the newly opened 244,000 sq ft Kenneth C. Griffin Cancer Research Building), the Diabetes Research Institute, the John P. Hussman Institute for Human Genomics, the Miami Center for AIDS Research, and The Miami Project to Cure Paralysis. Technology platforms include proprietary AI systems such as GigaTIME (bone marrow biopsy predictive analytics for multiple myeloma), MILADS (agentic AI research assistant), Sylvester Data Portal (30,000+ tumor samples with 46% Hispanic representation), an AI-driven AR prostate biopsy system using HoloLens, multimodal dementia detection, nine deployed agentic pathology workflows via Microsoft Copilot Studio, and a $5 million 3D-bioprinting laboratory funded by NIH and the Department of Defense.

Revenue is generated through four primary streams: medical education tuition (M.D., M.D./Ph.D., dual-degree, and graduate programs), clinical care services via UHealth, external research grants from federal agencies (NIH, PCORI, DoD) and private foundations, and continuing medical education course fees. Marketing and outreach span owned channels (Inside U Miami Medicine podcast, Medicine Magazine, newsroom), social platforms across all major networks, hosted conferences and grand rounds, and a South Florida regional clinic and shuttle network. Core strategic partners include Microsoft, Neuralink (PRIME Study site), Jackson Health System, and the Miami VA Healthcare System.

Name

University of Miami Miller School of Medicine

Legal name

University of Miami Miller School of Medicine

Website

https://med.miami.edu

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

The University of Miami Miller School of Medicine is a private nonprofit academic medical center founded in 1952, integrating medical education, clinical care through UHealth, and biomedical research. It serves students, patients, and research participants via flagship institutes including Bascom Palmer (#1 eye hospital) and Sylvester Comprehensive Cancer Center.

Ownership category

akta.pro rank

Product category

Academic Medical Center

NAICS

Colleges, Universities, and Professional Schools (61131), Colleges, Universities, and Professional Schools (6113), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Colleges, Universities, and Professional Schools (611310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Academic medical center
• Medical education programs
• Clinical research services
• Patient care services
• Continuing medical education

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Education Tuition: Revenue from medical degree programs including M.D., M.D./Ph.D., and graduate studies. The school offers numerous dual-degree programs and ranks #1 for dual-degree medical graduates.
2. Clinical Care Services: Patient care revenue through UHealth University of Miami Health System delivering leading-edge patient care across multiple specialty areas including cancer, ophthalmology, diabetes, and more.
3. Research Grants and Funding: External research funding from federal agencies including NIH, PCORI, Department of Defense, as well as private foundations and industry partnerships. The school earned #1 position in Florida for NIH funding.
4. Continuing Medical Education: CME programs accredited by ACCME providing continuing education for physicians, generating revenue through course fees and subscriptions.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

The University of Miami Miller School of Medicine is an academic medical center that delivers medical education (M.D., M.D./Ph.D., graduate, postdoctoral, and continuing medical education programs), advanced patient care through the UHealth University of Miami Health System, and biomedical research across cancer, ophthalmology, diabetes, genomics, HIV, spinal cord injury, and other specialties. It operates major research institutes including Sylvester Comprehensive Cancer Center, Bascom Palmer Eye Institute, Diabetes Research Institute, and The Miami Project to Cure Paralysis.

Product overview

The University of Miami Miller School of Medicine is an academic medical institution offering a comprehensive portfolio of clinical care centers, research institutes, and educational programs. Key offerings include Sylvester Comprehensive Cancer Center (translational cancer research and care), Bascom Palmer Eye Institute (ranked #1 ophthalmology hospital for 24 years), Diabetes Research Institute (diabetes cure-focused research), John P. Hussman Institute for Human Genomics (genomics research), Miami Center for AIDS Research (HIV research), and The Miami Project to Cure Paralysis (spinal cord injury research). The institution has launched technology platforms including Sylvester Data Portal (clinical-genomic data integration), MILADS (AI research assistant), and GigaTIME (bone marrow analysis AI), alongside a $5 million 3D-bioprinting laboratory. Educational offerings span M.D. programs, graduate studies, M.D./Ph.D. training, postdoctoral programs, and ACCME-accredited continuing medical education.

Differentiator

Problem solved

Functional benefit

Brands

• UHealth – University of Miami Health System: University-based medical system delivering leading-edge patient care powered by Miller School research.
• Sylvester Comprehensive Cancer Center
• Bascom Palmer Eye Institute

Products and services

• Sylvester Comprehensive Cancer Center University-based cancer center providing translational research from laboratory to patient bedside, treating a wide range of cancers across 15 site diseases from stage one to stage four.
• Bascom Palmer Eye Institute Department of Ophthalmology ranked #1 in the U.S. by U.S. News & World Report for 24 years, providing care across all ophthalmic subspecialties.
• Diabetes Research Institute World-leading cure-focused research center dedicated to developing a biological cure for diabetes by restoring natural insulin production and normalizing blood sugar levels.
• John P. Hussman Institute for Human Genomics (HIHG) Institute dedicated to using cutting-edge technologies to identify genes involved in human diseases for diagnosis, intervention, and prevention of illness.
• Miami Center for AIDS Research (CFAR) First NIH-funded AIDS research center in Florida, providing multipronged approach to combat HIV epidemic in the disproportionately impacted U.S. South region.
• The Miami Project to Cure Paralysis Global leader in spinal cord injury and traumatic brain injury research, having conducted FDA-approved Schwann cell implantation clinical trials and participating in Neuralink's PRIME study.
• Medical Scientist Training Program (M.D./Ph.D.) Combined M.D./Ph.D. program providing integrated research and clinical experience across eight programs in biomedical sciences, public health, and biomedical engineering.
• Continuing Medical Education (CME) ACCME-accredited continuing medical education program offering live courses, online courses, grand rounds, and license renewal programs for physicians.
• M.D. Degree Programs (NextGenMD Curriculum) Revolutionary medical education curriculum equipping Miller School students with tools to become transformational leaders in medicine, with numerous dual-degree program options.
• UHealth University of Miami Health System - Clinical Care South Florida's only university-based medical system delivering leading-edge patient care across multiple specialty areas including cancer, ophthalmology, diabetes, cardiovascular, and neurological conditions.
• Sylvester Data Portal Cloud-based informatics platform integrating clinical and genomic data from multiple sources including major testing companies, providing access to more than 30,000 tumor samples with diverse patient population for cancer research queries.
• MIL Agentic Data Scientist (MILADS) Platform AI platform designed to assist researchers with study design, data management, and translating findings into clinical applications, developed through collaboration between multiple Miller School departments.
• 3D-Bioprinting Laboratory $5 million laboratory creating 3D-printed tissues, bones, and biological structures using living cells, proteins, and biomaterials for regenerative medicine and personalized treatments.
• GigaTIME AI Model AI model analyzing bone marrow biopsy slides to predict multiple myeloma patient response to specific therapies, enabling precision medicine treatment selection.

Quantifiable outcome

• Bascom Palmer Eye Institute ranked #1 eye hospital nationally for 24 consecutive years
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability17 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• DaybreakmajorStrategic or Co-development Partner · 12 June 2026Daybreak providing FDA-cleared oral appliance therapy and patient support services to participants in the OAT study arm across all trial sites for the $14 million PCORI-funded sleep apnea clinical trial.
• MicrosoftcoreTechnology or Integration · 8 June 2026Microsoft supported the 100-day Agentic AI Challenge through low-code platforms including Copilot Studio and Power Automate, enabling faculty, staff, and trainees to develop practical AI agents for clinical and administrative workflow automation.
• Accreditation Council for Continuing Medical Education (ACCME)coreStrategic or Co-development Partner · 8 June 2026Miller School is accredited by ACCME to provide continuing medical education for physicians, offering live courses, online courses, grand rounds, and license renewal programs.
• National Sleep FoundationminorStrategic or Co-development Partner · 14 April 2026Dr. Azizi Seixas contributed to National Sleep Foundation position statement on consumer sleep technology, shaping conclusions about technology's role in improving sleep health.
• The Miami Project to Cure ParalysiscoreStrategic or Co-development Partner · 31 March 2026Co-organized neuromodulation symposium with Miami Project to Cure Paralysis and South Florida SCI Model System, positioning University of Miami as global hub for spinal cord injury research.
• South Florida SCI Model SystemcoreStrategic or Co-development Partner · 31 March 2026Partnership for neuromodulation symposium bringing together international researchers, clinicians, engineers, and individuals with lived experience of spinal cord injury to advance neuromodulation technology into clinical care.
• HealthTree FoundationminorStrategic or Co-development Partner · 3 March 2026HealthTree Foundation registry provided patient data for Sylvester Comprehensive Cancer Center study on AI analysis of bone marrow images for myeloma care, enrolling 212 patients.
• Jackson Health SystemcoreStrategic or Co-development Partner · 15 January 2026Miami Project to Cure Paralysis continues partnership with Jackson Health System for advancing neurorehabilitation science through clinical trials and neuromodulation research, supported by federal agencies, private donors, and industry partners.
• Miami VA Healthcare SystemcoreStrategic or Co-development Partner · 15 January 2026Ongoing partnership for spinal cord injury and traumatic brain injury research, recognized as Center of Excellence in Spinal Cord Injury Research, with support from federal agencies, private donors, and industry partners.
• Neuralink CorporationcoreStrategic or Co-development Partner · 1 January 2025The Miami Project to Cure Paralysis was selected as the second U.S. site for Neuralink's PRIME Study exploring thought-controlled brain-computer interface devices for paralysis patients, successfully completing several Neuralink implants.

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Others

• Emory University School of Medicine:

Direct peers

• Johns Hopkins University School of Medicine: Top-tier U.S. academic medical center combining medical education, NIH-funded research, and a flagship hospital system. Closely comparable to Miller School in mission, structure, and competitive positioning for NIH funding, specialty rankings, and translational research. Dr. Ramulu, named incoming chair at Bascom Palmer, previously led at Hopkins' Wilmer Eye Institute.
• University of Florida College of Medicine: Florida's other major public medical school and Miller School's primary in-state competitor for NIH funding, clinical talent, and research grants. Comparable in education portfolio (MD, MD/PhD, graduate studies), basic and translational research, and clinical care delivery through an affiliated health system.
• Stanford University School of Medicine: Elite private U.S. medical school with a comparable combination of medical education, NIH-funded basic and clinical research, and a high-ranked academic hospital. Overlaps directly with Miller School in AI-driven biomedical research, biotechnology translation, and graduate medical training scale.
• Harvard Medical School: One of the largest U.S. academic medical institutions with extensive NIH funding, multiple teaching hospitals, and a broad biomedical research portfolio. Comparable to Miller School in graduate medical education, dual-degree programs, and translational pipeline development across oncology, neuroscience, and genomics.
• University of California, San Francisco School of Medicine: Top-5 NIH-funded U.S. medical school with major emphasis on biomedical research, AI/data science in medicine, and clinical translation through UCSF Health. Highly comparable to Miller School in mission, technology platform development, and translational research focus.
• Columbia University Vagelos College of Physicians and Surgeons: Private Ivy League medical school with strong NIH funding, MD/PhD program (similar to Miller School's MSTP), and an academic medical center in New York. Directly comparable in dual-degree education, neuroscience and spinal cord injury research, and senior faculty pedigree.
• Duke University School of Medicine: Private research medical school with top-10 NIH funding, a strong MD/PhD program, and major translational research portfolio. Comparable to Miller School in specialty clinical care, oncology research, and physician-scientist training through dedicated programs.
• University of Pennsylvania Perelman School of Medicine: Top NIH-funded private medical school with a fully integrated academic health system and extensive biomedical research portfolio. Directly comparable in translational research infrastructure, AI/precision medicine initiatives, and dual-degree medical education scale.
• Washington University School of Medicine in St. Louis: Top-5 NIH-funded private medical school with major emphasis on basic science research, genetics/genomics (Hussman Institute comparable to WashU's McDonnell Genome Institute), and clinical specialty centers. Closely comparable in research output density and institutional ranking profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/umiamimedicine
• YouTubeyoutube.com/@UMiamiMedicine
• Facebookfacebook.com/110761415623425
• LinkedInlinkedin.com/school/university-of-miami-miller-school-of-medicine
• Instagraminstagram.com/umiamimedicine
• TikToktiktok.com/@umiamimedicine

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Miami Miller School of Medicine